Connection

Diane Kamen to Glucocorticoids

This is a "connection" page, showing publications Diane Kamen has written about Glucocorticoids.
Connection Strength

1.158
  1. Corticosteroids in Lupus Nephritis and Central Nervous System Lupus. Rheum Dis Clin North Am. 2016 Feb; 42(1):63-73, viii.
    View in: PubMed
    Score: 0.470
  2. Impact of glucocorticoids on the incidence of lupus-related major organ damage: a systematic literature review and meta-regression analysis of longitudinal observational studies. Lupus Sci Med. 2021 12; 8(1).
    View in: PubMed
    Score: 0.180
  3. Economic Evaluation of Damage Accrual in an International Systemic Lupus Erythematosus Inception Cohort Using a Multistate Model Approach. Arthritis Care Res (Hoboken). 2020 12; 72(12):1800-1808.
    View in: PubMed
    Score: 0.168
  4. Glucocorticoid use and factors associated with variability in this use in the Systemic Lupus International Collaborating Clinics Inception Cohort. Rheumatology (Oxford). 2018 04 01; 57(4):677-687.
    View in: PubMed
    Score: 0.139
  5. Trends and Determinants of Osteoporosis Treatment and Screening in Patients With Rheumatoid Arthritis Compared to Osteoarthritis. Arthritis Care Res (Hoboken). 2018 05; 70(5):713-723.
    View in: PubMed
    Score: 0.139
  6. Antinuclear Antibody-Negative Systemic Lupus Erythematosus in an International Inception Cohort. Arthritis Care Res (Hoboken). 2019 07; 71(7):893-902.
    View in: PubMed
    Score: 0.038
  7. Lymphoma risk in systemic lupus: effects of disease activity versus treatment. Ann Rheum Dis. 2014 Jan; 73(1):138-42.
    View in: PubMed
    Score: 0.024
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.